PGY2 residency programs build upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available.
This unique PGY2 residency will be conducted at the two teaching hospitals of Emory Healthcare, Emory University Hospital (EUH) and Emory University Hospital Midtown (EUHM). The resident will provide care for diverse patient populations with challenging infectious diseases. EUH is a tertiary referral center where the residents will encounter patients with cystic fibrosis, immunocompromising conditions such as blood and marrow transplantation, hematological malignancies, and solid organ transplantation. At EUHM, the resident will care for medically complex patients in the following services: HIV, cardiovascular disease, end-stage renal disease, orthopedics, OB/GYN, neonatology, and ENT. The resident will also gain ambulatory care experience in medication management and adherence counseling at the Infectious Diseases clinic at EUHM. While both campuses are academic medical centers, EUHM also admits patients from community providers which will prepare the resident to practice in a variety of care settings.
The PGY2 Infectious Diseases pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in Infectious Diseases. This residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 Infectious Diseases pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification with added qualifications in Infectious Diseases.